ROME MEMORIAL HOSPITAL INC.
1. Target Overview & Investment Thesis
ROME MEMORIAL HOSPITAL INC. is a 79-bed under-performing / distressed in ONEIDA, NY with $91.3M in net patient revenue and a -20.1% operating margin. The hospital serves a payer mix of 29.9% Medicare, 2.2% Medicaid, and 67.9% commercial.
Thesis: Turnaround. Our ML models identify $6.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -20.1% to -12.7% (+736bps).
| Net Revenue HCRIS | $91.3M |
| Current EBITDA COMPUTED | $-18.3M |
| Operating Margin COMPUTED | -20.1% |
| Occupancy HCRIS | 43.6% |
| Revenue / Bed COMPUTED | $1.2M |
| Net-to-Gross HCRIS | 25.3% |
| Distress Probability ML | 48.7% |
2. Market Context & Competitive Position
NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -20.1% places it below the state median. Among 58 size-comparable peers (40-158 beds), the median margin is -16.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (40-158), prioritizing same-state peers. 58 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ROME MEMORIAL HOSPITAL INC. (Target) | NY | 79 | $91.3M | -20.1% |
| ROSWELL PARK CANCER INSTITUTE | NY | 142 | $772.3M | -40.1% |
| PHELPS MEMORIAL HOSPITAL CENTE | NY | 135 | $360.4M | -20.4% |
| CAYUGA MEDICAL CENTER AT ITHAC | NY | 107 | $302.3M | -13.1% |
| PECONIC BAY MEDICAL CENTER | NY | 130 | $294.3M | -9.3% |
| NEW YORK PRESBYTERIAN HUDSON V | NY | 128 | $249.3M | -9.5% |
| CANTON-POTSDAM HOSPITAL | NY | 94 | $231.6M | -5.7% |
| EPISCOPAL HEALTH SERVICES | NY | 126 | $214.7M | -50.0% |
| PLAINVIEW HOSPITAL | NY | 156 | $213.5M | -28.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $58K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-18.3M |
| + RCM Uplift | +$6.7M |
| Pro Forma EBITDA | $-11.6M |
| Current Margin | -20.1% |
| Pro Forma Margin | -12.7% |
| WC Released (1x) | $3.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-28.2M | $-53.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-28.2M | $-68.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-25.4M | $-55.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-25.4M | $-67.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-31.0M | $-78.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-31.0M | $-96.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 58 hospitals with 40-158 beds
- Same-state prioritization (n=59)
- Comp margins: P25=-30.0% / P50=-16.6% / P75=-9.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.